Trust Company of Vermont’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-55,993
Closed -$5.56M 1003
2019
Q3
$5.56M Sell
55,993
-3,146
-5% -$299K 0.45% 73
2019
Q2
$5.47M Sell
59,139
-2,355
-4% -$224K 0.45% 71
2019
Q1
$5.8M Sell
61,494
-9,020
-13% -$789K 0.5% 66
2018
Q4
$4.52M Sell
70,514
-5,299
-7% -$391K 0.44% 72
2018
Q3
$6.78M Buy
75,813
+3,328
+5% +$294K 0.57% 60
2018
Q2
$5.76M Buy
72,485
+2,314
+3% +$192K 0.52% 64
2018
Q1
$6.26M Buy
70,171
+12,861
+22% +$1.23M 0.59% 55
2017
Q4
$5.98M Buy
57,310
+5,010
+10% +$565K 0.56% 57
2017
Q3
$7.63M Buy
52,300
+1,434
+3% +$195K 0.76% 44
2017
Q2
$6.61M Buy
50,866
+4,168
+9% +$511K 0.68% 51
2017
Q1
$5.81M Buy
46,698
+659
+1% +$78.9K 0.63% 54
2016
Q4
$5.33M Buy
46,039
+2,348
+5% +$261K 0.61% 52
2016
Q3
$4.57M Buy
43,691
+1,411
+3% +$153K 0.57% 61
2016
Q2
$4.17M Buy
42,280
+79
+0.2% +$8.17K 0.55% 62
2016
Q1
$4.22M Buy
42,201
+2,929
+7% +$302K 0.59% 59
2015
Q4
$4.7M Buy
39,272
+412
+1% +$47.7K 0.67% 52
2015
Q3
$4.2M Buy
38,860
+4,258
+12% +$528K 0.65% 51
2015
Q2
$4M Buy
34,602
+2,053
+6% +$235K 0.58% 54
2015
Q1
$3.75M Buy
32,549
+846
+3% +$101K 0.55% 59
2014
Q4
$3.55M Buy
31,703
+358
+1% +$37.8K 0.52% 62
2014
Q3
$2.97M Buy
31,345
+865
+3% +$78.1K 0.45% 70
2014
Q2
$2.62M Buy
30,480
+2,394
+9% +$182K 0.4% 78
2014
Q1
$1.96M Buy
28,086
+1,558
+6% +$123K 0.32% 91
2013
Q4
$2.24M Sell
26,528
-2,234
-8% -$177K 0.38% 84
2013
Q3
$2.22M Buy
28,762
+48
+0.2% +$3.36K 0.41% 83
2013
Q2
$1.68M Buy
+28,714
New +$1.73M 0.33% 90

Other funds holding CELG

Trust Company of Vermont's CELG Position: Q4 2019 in Review

Trust Company of Vermont sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 55,993 shares — an estimated $5.56M sold.

Trust Company of Vermont first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $7.63M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Trust Company of Vermont reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Trust Company of Vermont sold 55,993 Celgene Corp shares in Q4 2019, an estimated $5.56M.
  • Trust Company of Vermont first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Trust Company of Vermont's Celgene Corp position peaked at $7.63M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Trust Company of Vermont's 13F filing for Q4 2019, filed 6 Feb 2020.